AP NEWS

The Corporate Reputation of Pharma, 2017: The Patient Perspective - Latin America Edition - ResearchAndMarkets.com

November 13, 2018

DUBLIN--(BUSINESS WIRE)--Nov 13, 2018--The “The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Latin America Edition” report has been added to ResearchAndMarkets.com’s offering.

Introducing the results of the 2017 (3rd) edition of The Corporate Reputation of Pharma - from the Perspective of Latin-American Patient Groups. In total, 71 Latin-American patient groups participated in the 2017 survey.

Latin-American patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from most other parts of the world. 50% of the Latin-American patient groups respondent to the 2017 survey stated that the industry’s overall corporate reputation was Excellent or Good. Though slightly down on the equivalent 2016 figure of 52%, the 2017 figure was higher than that from the full 2017 respondent body of 1,330 patient groups worldwide - 43%.

What Latin-American patient groups said on innovation and patient engagement in R&D:

More medicines for unmet patients’ needs. Defining unmet needs by listening to patients. Not using the above processes to leverage patient-group support.

Companies Featured

AbbVie AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly GSK Janssen Merck & Co/MSD Novartis Pfizer Roche (Genentech in the US) Sanofi Key Topics CoveredExecutive SummaryPatient-Group Relationships with Pharma, 2017Industry-Wide Findings, 2017Rankings of the 13 Pharma Companies, 2017 v. 2016 Among LatAm Patient Groups Familiar with the CompaniesPositionings of 7 Pharma Companies, 2017 v. 2016 Among US Patient Groups that Work/Partner with the CompaniesProfiles of the 13 Companies, 2017

For more information about this report visit https://www.researchandmarkets.com/research/vjc9j5/the_corporate?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181113005915/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/13/2018 11:27 AM/DISC: 11/13/2018 11:27 AM

http://www.businesswire.com/news/home/20181113005915/en

AP RADIO
Update hourly